Hemophilia Clinical Trials

A listing of Hemophilia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arkansas

UPDATED

Little Rock Arkansas 72202

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

California

UPDATED

Duarte California 91010

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Duarte California

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

Los Angeles California 90027

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

Los Angeles California

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

UPDATED

Sacramento California 95817

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

View More ▼

Sacramento California

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

UPDATED

San Diego California 92122

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

UPDATED

San Francisco California 94143

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Colorado

UPDATED

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Connecticut

UPDATED

New Haven Connecticut 06520

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

District of Columbia

UPDATED

Washington District of Columbia 20010

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Florida

Gainesville Florida 32610

Patients are needed to participate in a clinical research study evaluating Ankle and Knee Ultrasound Joint Assessment and Ankle and Knee Magnetic Resonance Imaging for the treatment of Hemophilia A or Hemophilia B

Miami Florida 33136

Patients are needed to participate in a clinical research study evaluating Ankle and Knee Ultrasound Joint Assessment and Ankle and Knee Magnetic Resonance Imaging for the treatment of Hemophilia A or Hemophilia B

UPDATED

St. Petersburg Florida 33701

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

UPDATED

Tampa Florida 33607

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Georgia

Atlanta Georgia 30322

A clinical research study of Recombinant FVIII Fc fusion product Eloctate, Recombinant FIX Fc fusion product Alprolix and Patient-operated diagnostic device for anemia AnemoCheck. for the treatment of Hemophilia or Menstrual Flow Excessive

UPDATED

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Illinois

Chicago Illinois

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

Peoria Illinois

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

UPDATED

Peoria Illinois 61615

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Indiana

UPDATED

Indianapolis Indiana 46260

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Indianapolis Indiana

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

UPDATED

Indianapolis Indiana 46260

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Kentucky

UPDATED

Louisville Kentucky 40202

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Louisiana

New Orleans Louisiana 70112

Patients are needed to participate in a clinical research study evaluating Ankle and Knee Ultrasound Joint Assessment and Ankle and Knee Magnetic Resonance Imaging for the treatment of Hemophilia A or Hemophilia B

UPDATED

New Orleans Louisiana 70112

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Maine

UPDATED

Brewer Maine 04412

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

UPDATED

Scarborough Maine 04074

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Maryland

UPDATED

Baltimore Maryland 21205

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Massachusetts

UPDATED

Boston Massachusetts 02115

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Michigan

UPDATED

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

UPDATED

Detroit Michigan 48202

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

UPDATED

East Lansing Michigan 48823

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

UPDATED

East Lansing Michigan 48823

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Minnesota

UPDATED

Minneapolis Minnesota 55404

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Missouri

UPDATED

Kansas City Missouri 64108

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

UPDATED

St. Louis Missouri 63104

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Nevada

UPDATED

Las Vegas Nevada 89109

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

New Hampshire

UPDATED

Lebanon New Hampshire 03756

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

New York

UPDATED

Buffalo New York 14209

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

UPDATED

New York New York 10065

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

UPDATED

New York New York 10065

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

UPDATED

Rochester New York 14621

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

UPDATED

Rochester New York 14621

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Ohio

UPDATED

Columbus Ohio 43205

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Oregon

UPDATED

Portland Oregon 97239

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Portland Oregon 97239

A Phase 3 clinical study for patients with Hemophilia or Bone Disease

UPDATED

Portland Oregon 97239

Patients are needed to participate in a clinical research study of Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 and Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 to evaluate Hemophilia

Pennsylvania

Hershey Pennsylvania

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B